In vitro inhibition of Escherichia coli β-glucuronidase by aripiprazole.
Saved in:
| Title: | In vitro inhibition of Escherichia coli β-glucuronidase by aripiprazole. |
|---|---|
| Authors: | Sugiyama K; Department of Legal Medicine, Graduate School of Medicine, Showa Medical University, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-0064, Japan., Sato K; Department of Sports and Health Sciences, Graduate School of Biomedical Engineering, Tohoku University, 6-6-12, Aramaki Aza Aoba-ku, Sendai, Miyagi, 980-8579, Japan. kensuke.sato.a7@tohoku.ac.jp.; Department of Adduct Biology and Gut Microbial Function, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, 6-11-11 Kitakarasuyama, Setagaya-ku, Tokyo, 157-8577, Japan. kensuke.sato.a7@tohoku.ac.jp., Aoki H; Department of Adduct Biology and Gut Microbial Function, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, 6-11-11 Kitakarasuyama, Setagaya-ku, Tokyo, 157-8577, Japan., Kotori M; Department of Adduct Biology and Gut Microbial Function, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, 6-11-11 Kitakarasuyama, Setagaya-ku, Tokyo, 157-8577, Japan.; Department of Clinical Research and Development, Graduate School of Pharmacy, Showa Medical University, Tokyo, Japan., Nakano R; Department of Physiology, Graduate School of Pharmacy, Showa Medical University, Tokyo, Japan., Hida N; Department of Clinical Research and Development, Graduate School of Pharmacy, Showa Medical University, Tokyo, Japan., Kusano M; Department of Legal Medicine, Graduate School of Medicine, Showa Medical University, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-0064, Japan. maiko-k@med.showa-u.ac.jp., Akiyama M; Department of Adduct Biology and Gut Microbial Function, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, 6-11-11 Kitakarasuyama, Setagaya-ku, Tokyo, 157-8577, Japan. akiyama.sw@med.showa-u.ac.jp. |
| Source: | Pharmacological reports : PR [Pharmacol Rep] 2026 Jun 04. Date of Electronic Publication: 2026 Jun 04. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer International Publishing Country of Publication: Switzerland NLM ID: 101234999 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2299-5684 (Electronic) Linking ISSN: 17341140 NLM ISO Abbreviation: Pharmacol Rep Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
